Vimarsana
Biggest News Aggregation in the World

Rhinoconjunctivitis Quality News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Rhinoconjunctivitis Quality. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Rhinoconjunctivitis Quality Today - Breaking & Trending Today

Altamira Therapeutics Announces Publication of Positive - Vimarsana News

Altamira Therapeutics Announces Publication of Positive

Hamilton, Bermuda, April 24, 2024 (GLOBE NEWSWIRE) -- Detailed results from randomized controlled Bentrio® trial in seasonal allergic rhinitis...

Altamira Therapeutics Reports Additional Significant Efficacy Outcomes from Bentrio Clinical Trial in Seasonal Allergic Rhinitis - Vimarsana News

Altamira Therapeutics Reports Additional Significant Efficacy Outcomes from Bentrio Clinical Trial in Seasonal Allergic Rhinitis

HAMILTON, BERMUDA , Sept. 14, 2023 --  Fresh data from randomized controlled NASAR clinical trial further demonstrate efficacy and tolerability of Bentrio® nasal spray in treatment of...

Neurent Medical: New Data show NEUROMARK Chronic Rhinitis Treatment Offers Significant Symptom Improvements - Vimarsana News

Neurent Medical: New Data show NEUROMARK Chronic Rhinitis Treatment Offers Significant Symptom Improvements

Results from the CLARITY Study Show the NEUROMARK® System Provides Safe and Effective Treatment for Patients with Chronic Rhinitis Neurent Medical, a company pioneering innovative non-surgical interventions

Combined Intranasal AR Treatment Better Than Monotherapy - Vimarsana News

Combined Intranasal AR Treatment Better Than Monotherapy

Corticosteroid plus an antihistamine improves nasal and ocular allergic rhinitis better than corticosteroid alone, researchers in Korea report.